Related Experiment Video
Updated: Aug 10, 2026
07:33
In vivo Dual Substrate Bioluminescent Imaging
Published on: October 11, 2011
New bioluminogenic substrates for monoamine oxidase assays
Wenhui Zhou1, Michael P Valley, John Shultz
1Promega Biosciences, Inc., 277 Granada Drive, San Luis Obispo, California 93401, USA. wenhui.zhou@promega.com
Journal of the American Chemical Society
|March 9, 2006
Summary
Researchers developed novel bioluminogenic substrates to measure monoamine oxidase (MAO) activity. These substrates enable sensitive assays for drug discovery and monitoring enzyme function in biological systems.
Area of Science:
- Biochemistry
- Enzyme kinetics
- Drug discovery
Background:
- Monoamine oxidase (MAO) enzymes are crucial targets in neuroscience and drug discovery.
- Existing assays for MAO activity often lack sensitivity or require complex procedures.
Purpose of the Study:
- To design and synthesize novel bioluminogenic substrates for sensitive detection of MAO A and MAO B activity.
- To develop a homogeneous assay for high-throughput screening (HTS) of MAO inhibitors.
Main Methods:
- Utilized a beta-elimination strategy to create luciferin derivatives.
- Modified the amino group and central core of luciferin scaffolds.
- Evaluated substrate performance using kinetic assays with purified MAO isozymes and known inhibitors.
Main Results:
- Developed a series of novel bioluminogenic substrates for MAO A, MAO B, or both.
- Identified a substrate with low Km values and high signal-to-background ratios for both isozymes.
- Demonstrated accurate measurement of MAO inhibitor Ki values using the developed substrate.
Conclusions:
- The novel substrates are effective tools for sensitive MAO activity assays.
- The developed homogeneous assay is suitable for HTS in drug discovery.
- The substrate design strategy can be extended to other enzyme assays and fluorogenic probes.
